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Blood ionized calcium (iCa) is a quantitative trait subject to
genetic influence. iCa is maintained in a narrow range
through the action of the calcium-sensing receptor (CASR)
controlling PTH secretion and calcium excretion. ACASR sin-
gle nucleotide polymorphism (SNP) prevalent in Caucasian
populations (A986S) has shown significant association with
iCa in a cohort of young women, but association with the
neighboring SNPs, R990G and Q1011E, has not been exam-
ined. We studied 377 unrelated adults (184 men and 193
women) recruited as healthy adults from a blood donor clinic.
The subjects were not taking any medications, nor did they
have disorders of calcium metabolism. Relative frequencies
for the CASR 986S, 990G, and 1011E minor alleles were 24%,
4%, and 3% respectively. At the A986S locus, subjects with the
AA genotype had significantly lower iCa (P  0.0001) than
subjects with one or two S alleles (mean  SE, 1.221  0.003 vs.
1.239 0.003mmol/liter). For the R990G site, subjects with the
RR genotype had higher iCa than those with one copy of the
990G allele (1.230  0.002 vs. 1.213  0.007 mmol/liter; P 
0.032). With respect to the 1011 locus, iCa was lower in QQ
genotype subjects than in the QE group (1.227  0.002 vs.
1.255  0.008 mmol/liter; P  0.002). After resolution of phase
for the doubly heterozygous subjects, analysis was conducted
on haplotypes across all three loci. As expected, subjects with
SRQ and ARE haplotypes are relatively hypercalcemic, and
those with AGQ are hypocalcemic, relative to subjects with
the common ARQ haplotype. Multiple regression analysis
with clinical covariates (age, sex and menopausal status, cre-
atinine, and PTH) showed that 16.5% of the total variance in
iCa may be explained, and the seven CASR haplotypes con-
tribute significantly (P < 0.0001) and substantially (49.1% of
the explained variance) to the model, with the following cor-
rected iCameans: ARQ/AGQ, 1.21 0.01; ARQ/ARQ, 1.22 0.01;
ARQ/SRQ, 1.24  0.01; SRQ/AGQ, 1.24  0.03; SRQ/SRQ, 1.25 
0.01; ARQ/ARE, 1.25 0.01; and SRQ/ARE, 1.27 0.01. Our data
confirm the association between iCa and the A986S locus and
suggest that R990G and Q1011E are also predictive. Given the
significant between-population variations in frequency of
variant alleles in thisCASRSNPcluster, tri-locus haplotyping
may prove to be more informative in studies of association
between variation in CASR and disease. (J Clin Endocrinol
Metab 89: 5634–5638, 2004)
SERUMCALCIUM IS a quantitative trait subject to geneticcontrol. Studies in mono- and dizygotic twins have
demonstrated that the variance in total calcium due to ge-
netic effects is between 50% and 78% (1, 2). Serum calcium
levels are maintained in a narrow range under the control of
PTH. The relationship between ionized calcium (iCa) and
PTH is mediated by the calcium-sensing receptor (CASR), a
G protein-coupled plasma membrane glycoprotein that is
expressed in the parathyroids and in renal tubular cells,
where it regulates calcium excretion (3). Single inactivating
or activating mutations of the CASR gene cause hypercal-
cemic or hypocalcemic disorders, known as familial hypocal-
ciuric hypercalcemia and autosomal dominant hypocalce-
mia, respectively (4, 5). This suggests a pivotal role of CASR
gene variants in extracellular calcium regulation. Heath et al.
(6) described three clustered polymorphisms in the intracel-
lular tail encoded by exon 7, inducing nonconservative
amino acid changes. Among these, the Ala986Ser (A986S)
polymorphism has been associated with population differ-
ences in serum calcium, suggesting that it is a significant
determinant of serum calcium levels, at least in North Amer-
ican cohorts (7, 8). Some have confirmed this effect in smaller
Caucasian samples (9, 10), but others have not (11–14). The
nearby nonconservative polymorphisms, Arg990Gly (R990G)
and Gln1011Glu (Q1011E), are more common in Asian (5, 15)
and Afro-American (5) populations, respectively, but have
not been carefully studied in relation to ionized calcium (16).
The aim of this study was to evaluate the frequency of the
A986S, R990G, and Q1011E polymorphisms and their asso-
ciation with ionized serum calcium in a large, well charac-
terized, adult cohort.
Abbreviations: CASR, Calcium-sensing receptor; iCa, ionized cal-
cium; SNP, single nucleotide polymorphism.
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Between April 2001 and September 2003, Caucasian adults were
prospectively recruited from a blood donor clinic in San Giovanni Ro-
tondo (Apulia, Italy). Subjects were excluded from additional study if
they were taking medication or known to be affected by diseases af-
fecting calcium metabolism. In those deemed eligible, iCa, serum cre-
atinine, and PTH were measured; measurements were excluded if re-
sults were outside the normal range. The final cohort of 377 subjects
consisted of 184 men (median age, 43 yr; range, 18–65 yr), 137 pre-
menopausal women (median age, 37 yr; range, 18–52 yr), and 56 post-
menopausal women (median age, 53 yr; range, 48–65 yr). All subjects
came from southeastern Italy, and most were residents of the Apulia
provinces. All patients gave informed consent, and the study, designed
according to Helsinki Declaration II, was approved by the ethical com-
mittee of Casa Sollievo della Sofferenza Hospital.
Genotyping
Genomic DNAwas extracted from peripheral white blood cells using
standard proteinase K-sodium dodecyl sulfate digestion and phenol-
chloroform extraction or the Wizard Genomic DNA Purification Kit
(Promega Corp., Madison WI). A fragment of exon 7 of 282 bp encom-
passing the three single nucleotide polymorphisms (SNPs) was ampli-
fied by PCR using the following primers: forward, 5-CAGATGCAAG-
CAGAAGGTCA-3; and reverse, 5-ACAAGTGCTGGGGACAACTC-
3. PCR conditions were initial denaturation at 95 C for 5 min; 35 cycles
at 95 C for 30 sec, 60 C for 30 sec, and 72 C for 30 sec; and a final extension
at 72 C for 10 min. Approximately 100 ng genomic DNA were used for
each sample. PCR controls with no DNA as template were used to
monitor potential reaction contamination. After purification with a Gel
Band Purification Kit (Amersham Biosciences, Piscataway, NJ), direct
sequencing of the 282-bp product was performed with an ABI BigDye
Terminator Cycle Sequencing Ready Reaction kit and an ABI PRISM
3100 Genetic Analyzer (Applied Biosystems, Warrington, UK).
Phasing of double heterozygotes
For subjects with ASRGQQ and ASRRQE genotypes, phasing was
undertaken with allele-specific amplification. For both genotypes,
genomic DNA was subjected to PCR with an allele-specific forward
primer 5-GCTTTGATGAGCCTCAGAAGAACG-3 and reverse primer
5-CTGTTTCCTGGACGGTCAGATCT-3, so that only the copywith the
A986-containing haplotype was amplified. PCR conditions were: initial
denaturation at 95 C for 12 min; then 35 cycles of denaturation at 95 C
for 30 sec, annealing at 52 C for 30 sec, and extension at 72 C for 30 sec;
followed by final extension at 72 C for 7 min. The product was mixed
with equal amounts of DNA similarly amplified from a subject ho-
mozygous across all three loci (AARRQQ), and the mixture was sub-
jected to denaturing HPLC at 65 C. For subjects with the downstream
variant allele in cis (ARQ/SGQorARQ/SRE), a shift in profile consistent
with heterozygosity would be expected. For subjects with the down-
streamvariant allele in trans (SRQ/AGQor SRQ/ARE), the profile of the
admixture remained unchanged.
Chemistries
Serum iCa (corrected to pH 7.4) was measured by ion-selective elec-
trode with an intraassay coefficient of variation of 3.4% and a reference
interval of 1.12–1.32 mmol/liter (AVL LIST GmbH Medizintechnik,
Graz, Austria). Serum creatinine was measured by a standard colori-
metric technique, and serum intact PTH was determined by the Allegro
immunoradiometric assay (Nichols Institute Diagnostics, San Juan Cap-
istrano, CA), which has intra- and interassay coefficients of variation of
5.1% and 8.2%, respectively, and a reference interval of 10–72 pg/ml.
Statistical analysis
Linkage and Hardy-Weinberg disequilibria were assessed using the
Genetic Data Analysis program (Lewis, P. O., and D. Zaykin, version
1.0d16c) based on standard methods described by Weir (17).
Differences among the measured analytes in relation to the single
locus genotypes and tri-locus haplotypes were performed by one-way
ANOVA and Duncan post hoc comparisons or t test for two-sample
unpaired data. Excluded from this associational analysis was the single
instance of 990G homozygosity (AGQ/AGQ), leaving 376 subjects in the
cohort. Differences in iCa and other parameters stratified by genetic
groupwere evaluated by one-way parametric ANOVA after assessment
for unequal sample variance.
To evaluate the effects of different covariates on calcium, general
linearmodelingwas used, based on iCa, corrected to pH7.4, as the single
dependent variable, genotype as an independent fixed predictor, and
age, creatinine, PTH, and gender/menopausal status as covariates. Data
are expressed as the mean se unless otherwise indicated. P 0.05 was
considered significant. All nongenetic analyses were performed using
the SPSS version 11.5 statistical package (SPSS, Inc., Chicago, IL).
Results
Clinical characteristics
For the entire cohort, there was a narrow distribution of
serum iCa values, as expected. The overall mean (sd) for all
376 subjects was 1.228  0.041 mmol/liter, with a range of
1.12–1.32 mmol/liter and no significant deviation from a
parametric distribution (by Kolmogorov-Smirnov test, P 
0.180). Mean serum creatinine was 0.88  0.17 (sd) mg/dl
(range, 0.47–1.35 mg/dl), and immunoreactive PTH was
40.3  13.3 (sd) pg/ml (range, 11.5–72 pg/ml). In a com-
parison of male and pre- and postmenopausal female
groups, we found no differences in iCa (1.225  0.003 vs.
1.226 0.004 vs. 1.241 0.006 mmol/liter, respectively; P
0.07) once valueswere corrected for creatinine, PTH, and age,
and stratification according to gender and postmenopausal
status was not further considered.
Single locus genotypes
Genotype frequencies for the three CASR loci are shown
in Table 1. There was no evidence of Hardy-Weinberg dis-
equilibrium, but the 986 and 990 loci showed small, but
significant, pairwise linkage disequilibrium. The coefficient
(0.0104  0.0018) was significantly different (2  12.9; P 
0.007) from zero. Exact test analysis of the tri-locus disequi-
librium using permutation methods gave probabilities close
to 0.05, suggesting a trend toward nonrandom association of
alleles.
Examining the cohort stratified according to single geno-
type (Table 1), we found no genotype-specific differences
with respect to age, serum PTH, or creatinine. However,
subjects with the common AA genotype at the A986S locus
had significantly lower iCa than subjects with one or two S
alleles (1.221  0.003 vs. 1.239  0.003 mmol/liter; P 
0.0001), andANOVAshowed a significant trend for iCa,with
S as the hypercalcemic allele (F for trend 10.48; P 0.0013).
For the R990G locus, however, subjects with the common RR
genotype had higher iCa than those with a 990G allele
(1.230 0.002 vs. 1.213 0.007mmol/liter; P 0.032). When
grouped byQ1011E genotype, subjects with the commonQQ
genotype had lower iCa than those with the QE genotype
(1.227  0.002 vs. 1.255  0.008 mmol/liter; P  0.002;
Table 1).
Tri-locus haplotypes
Haplotyping of the double heterozygotes revealed that all
of the minor alleles were present in the trans configuration.
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Of the four ASRGQQ subjects, all were SRQ/AGQ, and all
five ASRRQE subjects were haplotyped as SRQ/ARE. Anal-
ysis of all haplotypes by exact test for Hardy-Weinberg dis-
equilibrium did not reach significance (P  0.37), but the
small numbers of mutant homozygotes seriously limit the
power of any test for nonrandom association of alleles.
Examining the sample stratified according to tri-locus hap-
lotypes (Table 2), we found no haplotype-specific differences
with respect to age, serum PTH, or creatinine. Subjects ho-
mozygous for the ARQ/ARQ genotype had significantly
lower iCa than subjects with none (P  0.0001) or one (P 
0.038) of the common alleles, and ANOVA showed a signif-
icant trend for iCa, with ARQ as the hypocalcemic haplotype
(F for trend 17.27;P 0.0001). Stratified by SRQhaplotype,
subjects without any SRQ allele had significantly lower iCa
than subjects with one (P  0.001) or two (P  0.004) alleles,
and ANOVA showed a significant trend for iCa, with SRQ
as the hypercalcemic haplotype (F for trend  10.48; P 
0.001). For the AGQ haplotype, however, subjects with the
AGQ haplotype had lower iCa than those without it (P 
0.032). When grouped by ARE haplotype, subjects with the
ARE haplotype had higher iCa than those without it (P 
0.002).
Haplotypes and multiple regression analysis
Mean iCa values according to the seven tri-locus haplo-
type groups are given in Table 3. After adjustment for the
other covariates, haplotypes with ARE or SRQ and without
AGQ alleles were associated with higher adjusted iCa con-
centrations (P  0.05) compared with ARQ/ARQ or AGQ/
ARQgenotypes (Fig. 1).Multiple regression analysis showed
that all variables together accounted for 16.5% of the total
variance in iCa (F  7.24; P  0.0001), and haplotype was a
significant predictor (F  5.94; P  0.0001), accounting for
nearly half (49.1%) of the explained variance for iCa in this
model.
Discussion
Twin studies indicate that the variance of serum calcium
is primarily due to genetic effects (1, 2). TheCASRprotein has
a central role in mediating the relationship among iCa, PTH,
and renal handling of calcium. Indeed, activating and inac-
tivatingmutations of CASR induce opposite effects on serum
and urinary calcium, resulting in hypocalciuric hypercalce-
mia and hypercalciuric hypocalcemia, respectively (4, 5).
These relatively rare disorders suggest that SNPs might be
TABLE 1. Clinical characteristics according to single-locus genotypea
Locusb Genotype
Clinical characteristic
nc Age (yr) iCa (mmol/liter) PTH (pg/ml) Creatinine (mg/dl)
A986S AA 223 43.0  0.8 1.221  0.003d,e 39.7  0.9 0.87  0.01
AS 126 43.3  1.1 1.237  0.004 41.6  1.2 0.89  0.02
SS 27 40.4  2.6 1.247  0.007 39.5  2.8 0.91  0.03
R990G RR 345 42.8  0.7 1.230  0.002f 40.3  0.7 0.88  0.01
RG 31 43.8  2.1 1.213  0.007 40.0  2.6 0.90  0.03
Q1011E QQ 355 43.0  0.6 1.227  0.002g 40.3  0.7 0.88  0.01
QE 21 41.4  2.6 1.255  0.008 41.4  2.9 0.90  0.03
a Mean  SE.
b No evidence was found for Hardy-Weinberg disequilibrium at any of the three loci, analyzed by Fisher exact test (17).
c Number of subjects.
d P  0.001 for AA vs. AS; e P  0.004 for AA vs. SS, by one-way ANOVA and Duncan post hoc comparison.
f P  0.032 for RR vs. RG, by t test for unpaired data.
g P  0.002 for QQ vs. QE, by t test for unpaired data.
TABLE 2. Clinical characteristics according to tri-locus haplotypea
Allele Haplotype
Clinical data
nb Age (yr) iCa (mmol/liter) PTH (pg/ml) Creatinine (mg/dl)
ARQ X/Xc 36 40.4  2.3 1.251  0.006d,e 40.2  2.4 0.92  0.03
X/ARQ 160 43.5  0.9 1.232  0.003 41.2  1.1 0.89  0.01
ARQ/ARQ 180 42.9  0.9 1.220  0.003 39.6  1.0 0.87  0.01
SRQ X/X 223 43.0  0.8 1.221  0.003f,g 39.7  0.9 0.87  0.01
X/SRQ 126 43.3  1.1 1.237  0.004 41.6  1.2 0.89  0.02
SRQ/SRQ 27 40.4  2.6 1.247  0.007 39.5  2.8 0.91  0.03
AGQ X/X 345 42.8  0.7 1.230  0.002h 40.3  0.7 0.88  0.01
X/AGQ 31 43.8  2.1 1.213  0.007 40.0  2.6 0.90  0.03
ARE X/X 355 43.0  0.6 1.227  0.002i 40.3  0.7 0.88  0.01
X/ARE 21 41.4  2.6 1.255  0.008 41.4  2.9 0.90  0.03
a Mean  SE.
b Number of subjects.
c X  Any other haplotype.
d P  0.038 for X/X vs. X/ARQ; e P  0.0001 for X/X vs. ARQ/ARQ, by one-way ANOVA and Duncan post hoc comparison.
f P  0.001 for X/X vs. X/SRQ; g P  0.004 for X/X vs. SRQ/SRQ, by one-way ANOVA and Duncan post hoc comparison.
h P  0.032 for X/X vs. X/AGQ, by t test for unpaired data.
i P  0.002 for X/X vs. X/ARE, by t test for unpaired data.
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predictive of extracellular iCa in healthy populations (18, 19).
In a cohort of premenopausal Caucasian females, serum cal-
cium was found to be associated with the A986S polymor-
phism (7, 8). This SNP may thus be a genetic determinant of
serum calcium and a candidate for predisposition to diseases
of mineral metabolism. The two other polymorphisms clus-
tered in the intracellular tail of CASR, namely R990G and
Q1011E, are less common in Caucasians and more frequent
in Asiatics and Africans, respectively (5, 16), but significant
association with serum calcium levels has not been studied
in detail.
In our larger cohort of healthy male and female adults, we
found that the 986S allele is relatively common (28.8%), and
the similar findings of Vezzoli et al. (10) suggest that it may
exist at a higher background frequency in some Italian pop-
ulations than in other groups (7–9, 11, 12), including the
Toronto cohort (16.3%; P  0.006). The association of in-
creased iCa with 986S, previously reported by others and us
(7–10), is confirmed in the present study. Three other groups
have examined the relationship between extracellular cal-
cium and the A986S polymorphism without finding a sig-
nificant association. In a German cohort, investigators ana-
lyzed corrected serum calcium in a smaller number of
subjects (n  102) and found no correlation. However, they
reported a trend toward higher calcium levels in subjects
with one or two 986S alleles (12). More recently, Young et al.
(13) and Bollerslev et al. (14) analyzed calcium data for 102
and 252 postmenopausal women, respectively, and reported
no difference in circulating calcium levels based on A986S
genotype. In the latter study, the older age of the cohort may
also be a factor, but it is interesting to note that the relative
difference between groups with and without a 986S allele in
their study (0.9%) was not substantially different from ours
(1.4%), and they reported a trend toward higher calcium
(adjusted for albumin) in subjects bearing a 986S allele.
The present study provides additional evidence for cor-
relation of the ionized calcium phenotype with CASR geno-
types. The prevalence of the 990G variant allele was different
from that in the North American cohort (4.4% vs. 13.2%
respectively; P  0.0001), and it was associated with signif-
icantly lower iCa in this population, a finding not observed
in 44 Japanese subjects (16) with a much higher background
prevalence (56.8%). Whether the findings in the Japanese
reflect the small sample size is unclear. Although the prev-
alence of the Q1011E polymorphism was not different from
that in the North American cohort (2.8% vs. 4.3%, respec-
tively; P 0.27), an isolated 1011E allele was associated with
the largest difference in iCa. Whether this relationship will
be confirmed in other populations with a higher 1011E prev-
alence remains to be seen.
Interestingly, the haplotypes were significantly associated
with iCa values. In fact, the wild-type genotype (homozy-
gous ARQ) and the genotype bearing the 990G (AGQ) were
associated with a lower iCa value, whereas those bearing the
986S (SRQ) and 1011E (ARE)were hypercalcemic. According
to these results, the composite genotypes obtained by group-
ing the four different haplotypes also support a robust as-
sociation of CASR variants with iCa. In our cohort, we found
that iCa decreased in a graded fashion according to geno-
type, the order being (from highest to lowest): SRQ/
AREARE/ARQSRQ/SRQSRQ/AGQSRQ/ARQ
ARQ/ARQ (wild-type)AGQ/ARQ. Because of method-
ological differences in the measurement of iCa, direct com-
parison of different studies is not possible. However, nor-
malization of iCa values allows us to compare trends. In
both the European cohort and the Canadian study (Table 4),
the AGQ haplotype is associated with modest hypocalce-
mia, whereas the SRQ haplotype is hypercalcemic and dem-
onstrates a gene dosage effect. Although the associations
with the ARE haplotype are discordant, the number of
patients with that haplotype in the Canadian cohort is very
FIG. 1. iCa concentrations according to tri-locus CASR haplotype.
Values are adjusted for age, gender/menopausal status, serum cre-
atinine, and PTH using general linear modeling. Groups sharing the
same letter (above the error bar) are not significantly different (P 
0.05).
TABLE 3. Mean iCa concentrations according to CASR haplotype
Haplotype n iCa (mmol/liter)
AGQ/ARQ 27 1.208  0.007a
ARQ/ARQb 180 1.220  0.003
SRQ/ARQ 117 1.235  0.004
SRQ/AGQ 4 1.246  0.030
SRQ/SRQ 27 1.247  0.007
ARE/ARQ 16 1.250  0.011
AGQ/AGQ 1 1.270
SRQ/ARE 5 1.272  0.006
a Data are expressed as mean  SE.
b Common haplotypes are in boldface.
TABLE 4. Ionized calcium by haplotype in European and North-Americana cohorts
AGQ/ARQ ARQ/ARQ SRQ/ARQ SRQ/SRQ ARE/ARQ
Toronto 0.366  1.008b (12) 0.097  0.805 (30) 0.218  0.992 (26) 0.276  0.489 (4) 0.183  0.905 (8)
Apulia 0.277  0.783 (27) 0.072  0.732 (180) 0.057  0.840 (117) 0.480  0.800 (27) 0.415  0.974 (16)
a Haplotypes and iCa concentrations for the North-American cohort derived from the data set previously published (7).
b Values [mean  SD (n)] for iCa transformed to the standard normal function, with mean of zero and SD of one.
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small. More relevant, perhaps, are observations by other
investigators (10, 12) that also suggest higher serum calcium
values associated with the 1011E genotype.
The multiple regression analysis showing the substantial
predictive power of the genotypes on calcium (accounting
for about half the variance) also confirms the strength of the
multilocus association. That the new cohort was comprised
of men and women allowed us to ask whether there were
gender-specific effects, but we found none.
The functional properties of the three missense variants in
the CASR intracellular tail remain unknown. At present,
there is little evidence that they are disease-causing, but their
potential role in disease predisposition is stimulating con-
siderable interest. On the basis of a CASR polymorphism
haplotype study in stone-forming patients, it was suggested
that the 990G variant could influence renal CASR activation
and calcium excretion (10). Thus, the tri-locus haplotypemay
be important in predisposition to renal stones in some frac-
tion of individuals with nephrolithiasis. However, in indi-
viduals affected by primary hyperparathyroidism (12),
osteoporosis (20), or fragility fractures (21), CASR polymor-
phisms were not associated with clinical phenotype.
In conclusion, our study confirms the association of in-
creased iCa with the 986S variant allele, but also indicates
that the two neighboring loci of exon 7 of CASR are signif-
icant predictors. This SNP cluster is an interesting candidate
for studying the susceptibility of diseases of calcium metab-
olism.Moreover, given the between-population variations in
the prevalence of variant alleles in CASR SNPs, tri-locus
haplotyping could be more informative in studies of asso-
ciation between variation in CASR and disease.
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